BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/04/2026

FDA Clears REVIA Tablets for Sale

The FDA has determined that REVIA tablets, 50mg, were not withdrawn from sale due to safety or effectiveness concerns, allowing the agency to continue approving abbreviated new drug applications for the product.

Source: Federal Register — Food and Drug AdministrationOpen original release →